MYRIAD GENETICS INC — Director's Dealing 2021

Apr 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-04-27

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-27	Common Stock	M	40000	$19.47	Acquired	305922	Direct
2021-04-27	Common Stock	S	40000	$31.47	Disposed	265922	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-27	Non-Qualified Stock Option (right to buy)	$19.47	M	40000	Disposed	2021-09-13	Common Stock (40000)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The shares subject to this option are fully vested and exercisable.